Eleanor Platt
Eleanor Platt is a Molecular Scientist within the Biomarkers team at Medicines Discovery Catapult. Eleanor undertook a degree in Molecular and Cellular Biology at the University of Bath and completed her M.Phil. in Molecular Cancer Studies at the University of Manchester, with a focus on the role of glucocorticoid receptor in small cell lung cancer […]
Constance Takawira
Constance joined the team as the Partnership Manager for the CF AMR Syndicate. Constance’s main background is in clinical pharmacy, working both in the UK and in New Zealand. During her time in New Zealand, she specialised in respiratory medicine and served as a member of the antimicrobial stewardship committee. Her current focus is on […]
Dr Beverley Isherwood
Beverley has responsibility for setting up and providing strategic and scientific leadership and direction for MDC’s infectious disease Syndicate portfolio, including the CF AMR Syndicate. Bev has extensive experience in the development and delivery of collaborative research consortia bringing together experts from different sectors to shape research agendas and drive research efforts focused on unmet […]
Gayle Marshall
Gayle has more than 20 years of experience, in biomarker and omics research. Leading a large, multi-skilled translational science laboratory team, within a global Pharma department supporting biomarker strategies across 14 drug discovery programs covering more than 20 clinical studies, through to leading a large multi-disciplinary team within MDC. Gayle directs multi-biomarker analysis and assay […]
Dr Hervé Barjat
Following undergraduate studies in chemistry at Université Claude Bernard in Lyon, and an M.Sc. in physical methods of chemical analysis at UEA, he specialised in NMR spectroscopy whilst studying for a PhD at the University of Manchester with Prof. Gareth Morris. He developed novel data acquisition methods as well as analysis tools in high-field liquid-state […]
Dr Ekta Patel
Ekta is responsible for the management of the Psychiatry Consortium. Ekta is a translational scientist with over 8 years of drug discovery research experience in both academic and industrial roles. Combining her scientific knowledge and experience of working across SMEs, academic research groups and pharmaceutical companies, Ekta provides in-depth support to our collaborators to develop […]
Dr Kirsty Winn
Kirsty Winn is a cell biologist and pharmacologist experienced in early drug discovery and lead generation. Kirsty joined MDC in 2020 as an External Drug Discovery Project Lead; responsible for providing drug discovery advice, scientific due diligence and robust research plans alongside UK medicines discovery innovators. Prior to MDC Kirsty led integrated drug discovery programmes […]
Sarah Brockbank
Sarah Brockbank leads the strategy for Complex Medicines at Medicines Discovery Catapult. In this role she draws on internal expertise and the external environment, through membership of national programmes and a portfolio of client projects, to develop and implement a core strategy for complex medicines that is responsive to the needs of this emerging area. […]
Dr Graeme Wilkinson
Graeme is Head of Virtual R&D at Medicines Discovery Catapult. A pharmacologist by training, and with over 25 years of experience in the industry, Graeme has a track record of successfully leading drug discovery and capability enhancement projects in large pharma and start-up across many disease areas. In addition, Graeme has also significant experience in […]